Skip to main content
. 2022 Sep 27;15(12):2928–2937. doi: 10.1111/cts.13410

TABLE 1.

Final pharmacokinetic and pharmacodynamic parameter estimates

Parameter Estimate (95% CI) %RSE
CL, L/min 26.0 (20.6–33.6) 15.1
Q, L/min 2.99 (1.87–5.44) 36.6
Vc, L 221 (181–273) 12.1
Vp, L 59.0 (48.0–82.7) 18.5
CL(m), L/min 0.093 (0.076–0.11) 10.6
V(m), L 9.55 (8.07–11.1) 9.8
BSV CL, CV% 47.3 (37.5–65.3) 41.0
BSV V(m), CV% 29.0 (21.7–41.5) 45.0
Residual error DMT, CV% 50.0 (43.9–58.9) 19.2
Residual error IAA, CV% 19.0 (16.8–21.8) 16.3
E max 10 FIX
EC50,e, nM 94.7 (75.4–123) 14.9
k e0, min−1 1.38 (1.16–1.94) 17.5
γ 2.87 (2.63–3.02) 4.2
BSV EC50,e, CV% 38.6 (29.1–50.4) 34.1
BSV γ, CV% 77.3 (58.1–103) 36.6
Residual error intensity ratings, SD 0.82 (0.55–0.90) 7.8

Abbreviations: BSV, between subject variability; CI, confidence interval; CL, clearance for N,N‐dimethyltryptamine; CL(m), clearance for indole 3‐acetic acid; CV%, coefficient of variation percentage; DMT, N,N‐dimethyltryptamine; EC50,e, the concentration in the effect compartment needed to achieve 50% of the maximum response; E max, maximum achieved psychedelic intensity; IAA, indole 3‐acetic acid; k e0, the effect compartment equilibrium rate constant; Q, intercompartmental clearance for N,N‐dimethyltryptamine; Vc, central volume of distribution for N,N‐dimethyltryptamine; V(m), volume of distribution for indole 3‐acetic acid; Vp, peripheral volume of distribution for N,N‐dimethyltryptamine; γ, Hill coefficient describing the steepness of the relationship.